Elevated BCL2 levels are also seen in chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), and acute myeloid leukemia (AML), contributing to poor treatment response [25]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.